Ask Warren

Tera Science

073640 · KOSDAQ · ₩073640 · 테라사이언스

₩654 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩3.9B₩3.8B₩3.4B₩3.3B₩3.6B₩3.7B₩3.4B₩3.8B
Cost of sales₩3.3B₩3.2B₩3.5B₩2.9B₩3.2B₩3.2B₩3.3B₩3.2B
Gross profit₩617M₩524M−₩62M₩412M₩463M₩593M₩133M₩563M
Operating income−₩2.1B−₩1.7B−₩2B−₩2.5B−₩2.6B−₩3B−₩2.3B−₩2.3B
Net income—−₩2B−₩7.3B−₩2.6B−₩1.7B−₩5.7B−₩423M−₩2.3B
Net income to shareholders—−₩2B−₩7.2B−₩2.6B−₩1.7B−₩5.7B−₩394M−₩2.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩55B₩56B₩56B₩73B₩81B₩85B₩79B₩81B
Current assets₩34B₩18B₩18B₩28B₩30B₩34B₩24B₩37B
Cash and equivalents₩2.6B₩927M₩2B₩1.9B₩5.5B₩3.7B₩2.9B₩1B
Total liabilities₩29B₩29B₩28B₩17B₩22B₩23B₩11B₩15B
Current liabilities₩25B₩25B₩24B₩14B₩19B₩20B₩8.3B₩13B
Borrowings₩61M₩61M₩61M₩3B₩3B₩3B₩3B₩3B
Total equity₩26B₩27B₩29B₩56B₩59B₩62B₩68B₩66B
Shareholders' equity₩26B₩27B₩29B₩56B₩58B₩61B₩67B₩65B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩2.7B−₩2B−₩3.5B−₩3.4B−₩2.7B−₩3.5B−₩506M−₩1.3B
Capital spending——₩160M₩8.9M₩187M₩116M₩0−₩116M
Free cash flow−₩2.7B−₩2B−₩3.6B−₩3.4B−₩2.9B−₩3.6B−₩506M−₩1.4B

Consolidated where available. Amounts in won.

Also known as: Tera Science / 테라사이언스 / 073640 / KRX:073640

Source: KRX statistical information